Press release regarding the meeting of the Competition Council Section – Held on Wednesday, November 26, 2025

Latest News

Logo
Press Releases
Statement from the Competition Council regarding the economic concentration project concerning the joint takeover of the ‘African Company for Special Studies and Works SARL’ (SAFETTRAS) by the company ‘General Construction Works of Casablanca SA’ (TGCC) alongside historical shareholders Mr. Salah El Mouda and Mr. Khali Moulay Lhassan.
Logo
Press Releases
Press release from the Competition Council regarding the economic concentration project concerning the exclusive takeover by the company “BCPE Lightning Buyer, Inc.” of the companies “FDH Defense Aftermarket, Inc.” and “FDH Group Intermediate, Inc.”
Logo
Press Releases
Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the fund «Fonds Génération Entrepreneurs I FPCC-RFA » of joint control of the company «Kartner Glass Industry SAS», alongside its historical shareholder «Kartner Invest SAS AU»
Logo
Press Releases
Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company “Tanger Med Port Authority SA” of joint control of the company “Portnet SA”, alongside the historical shareholder the “National Ports Agency”
Logo
Press Releases
Press release from the Competition Council regarding the economic concentration project related to the merger between the company “Akzo Nobel N.V.” and the company “Axalta Coating Systems Ltd.”

In accordance with Article 38 of the Internal Regulations of the Competition Council, the Council Section held a meeting on Wednesday, November 26, 2025 at 11:00 am, under the chairmanship of Mr. Hassan Abouabdelmajid, Vice-President of the Competition Council, to examine the file submitted to it by the Council’s investigation and inquiry services.

The Section then decided to authorize the following economic concentration operation:

  • Direct and indirect acquisition by the company “Laprophan S.A” of joint control of the companies “Pian Holding B.V.”, “Double-e Pharma Limited” and “Rivopharm Limited”, alongside Mr. Piero Luigi Umberto Poli.